Hutchison China MediTech Ltd ADR Stock
Currently there is a rather positive sentiment for Hutchison China MediTech Ltd ADR with 3 Buy predictions and 1 Sell predictions.
As a result the target price of 17 € shows a positive potential of 42.86% compared to the current price of 11.9 € for Hutchison China MediTech Ltd ADR.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | - | 0.000% | -9.848% | -29.167% | -11.194% | -1.653% | -50.000% |
| China Resources Pharmaceutical Group Ltd | -0.950% | 0.000% | -3.670% | -17.323% | -22.222% | -33.121% | 23.821% |
| China Traditional Chinese Medicine Co Ltd | -0.820% | -1.613% | 0.000% | -9.630% | -10.294% | -46.018% | -38.071% |
| Repligen Corp. | -0.880% | -4.075% | 11.207% | 0.743% | 1.751% | -20.349% | -8.247% |
Comments
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (NASDAQ:HCM) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $13.75 price target on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) had its price target raised by analysts at Bank of America Corporation from $27.00 to $28.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat